Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study

被引：0
|
作者：
Weijie Wang
Yu-Hsun Wang
Ching-Hua Huang
Tsung-Hsueh Hsieh
Gema Hernández Ibarburu
James Cheng-Chung Wei
机构：
[1] The Second Affiliated Hospital of Zhejiang Chinese Medical University,Department of Rheumatology
[2] Institute of Basic Theory for Chinese Medicine,Department of Medical Research
[3] China Academy of Chinese Medical Science,Department of Allergy
[4] Chung Shan Medical University Hospital,Department of Medical Research
[5] Immunology & Rheumatology,Department of Pharmacy
[6] Chung Shan Medical University Hospital,undefined
[7] Institute of Medicine,undefined
[8] Chung Shan Medical University,undefined
[9] Graduate Institute of Integrated Medicine,undefined
[10] China Medical University,undefined
[11] Taichung Veterans General Hospital,undefined
[12] Chung Shan Medical University Hospital,undefined
[13] Senior TriNetX Healthcare Partnership Manager EMEA,undefined
[14] TriNetX,undefined
来源：
BMC Medicine | / 22卷
关键词：
Paxlovid; COVID-19; Autoimmune rheumatic diseases; Cardiovascular outcomes; TriNetX;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study
    Wang, Weijie
    Wang, Yu-Hsun
    Huang, Ching-Hua
    Hsieh, Tsung-Hsueh
    Ibarburu, Gema Hernandez
    Wei, James Cheng-Chung
    BMC MEDICINE, 2024, 22 (01)
  • [2] Risk of autoimmune diseases in patients with COVID-19 a retrospective cohort study
    Chang, Renin
    Chen, Thomas Yen-Ting
    Wang, Shiow-Ing
    Hung, Yao-Min
    Chen, Hui-Yuan
    Wei, Cheng-Chung James
    ECLINICALMEDICINE, 2023, 56 : 1 - 13
  • [3] Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study
    Chang, Renin
    Chen, Thomas Yen-Ting
    Wang, Shiow-Ing
    Hung, Yao-Min
    Chen, Hui-Yuan
    Wei, Cheng-Chung James
    ECLINICALMEDICINE, 2023, 56
  • [4] RISK OF COVID-19 IN PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES
    不详
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2021, 125 (01): : 41 - 41
  • [5] Risk Factors Associated with COVID-19 Breakthrough Infection Among Patients with Systemic Autoimmune Rheumatic Diseases: A Cohort Study
    Patel, Naomi
    Wang, Xiaosong
    Fu, Xiaoqing
    Kawano, Yumeko
    Cook, Claire
    Vanni, Kathleen
    Qian, Grace
    Banasiak, Emily
    Kowalski, Emily
    Zhang, Yuqing
    Sparks, Jeffrey
    Wallace, Zachary
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1419 - 1422
  • [6] COVID-19 Mortality and Hospitalization Risk in Patients with Rheumatic Diseases: A Single Center Retrospective Cohort Study
    Albalwi, Mousa
    Brintz, Ben
    Beddhu, Srinivasan
    Wei, Guo
    Thomas, Julie
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 206 - 207
  • [7] Outcomes of COVID-19 in Inflammatory Rheumatic Diseases: A Retrospective Cohort Study
    Alhowaish, Thamer Saad
    Alhamadh, Moustafa S.
    Alhabeeb, Abdulrahman Yousef
    Aldosari, Shaya Fahad
    Masuadi, Emad
    Alrashid, Abdulrahman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [8] COVID-19 and autoimmune rheumatic diseases
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (10): : E593 - E593
  • [9] Evolution of COVID-19 in patients with autoimmune rheumatic diseases
    Pang, Rongrong
    Zhao, Jun
    Gan, Zhenhua
    Hu, Zhiliang
    Xue, Xiang
    Wu, Yanjun
    Qiao, Qinghua
    Zhong, Aifang
    Xia, Xinyi
    Liao, Hui
    Wang, Zhihua
    Zhang, Libo
    AGING-US, 2020, 12 (23): : 23427 - 23435
  • [10] Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study
    Mahmoudi, Hamidreza
    Farid, Ali Salehi
    Nili, Ali
    Dayani, Dorsa
    Tavakolpour, Soheil
    Soori, Tahereh
    Teimourpour, Amir
    Isazade, Ahdie
    Abedini, Robabeh
    Balighi, Kamran
    Daneshpazhooh, Maryam
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (04) : 1098 - 1100
12345